RÉSUMÉ
Bovine viral diarrhea virus (BVDV) is the cause of bovine viral diarrhea disease, one of the most economically important livestock diseases worldwide. The majority of BVD disease control programs rely on the detection and then elimination of persistent infection (PI) cattle, as the continuing source of disease. The main purpose of this study was to design and develop an accurate G-quadruplex-based aptasensor for rapid and simple detection of BVDV-1. In this work, we utilized in silico techniques to design a G-quadruplex aptamer specific for the detection of BVDV-1. Also, the rationally designed aptamer was validated experimentally and was used for developing a colorimetric biosensor based on an aptamer-gold nanoparticle system. Firstly, a pool of G-quadruplex forming ssDNA sequences was constructed. Then, based on the stability score in secondary and tertiary structures and molecular docking score, an aptamer (Apt31) was selected. In the experimental part, gold nanoparticles (AuNPs) with an average particle size of 31.7 nm were synthesized and electrostatically linked with the Apt31. The colorimetric test showed that salt-induced color change of AuNPs from red to purple-blue occurs only in the presence of BVDV-Apt31 complex, after 20 min. These results approved the specificity of Apt31 for BVDV. Furthermore, our biosensor could detect the virus at as low as 0.27 copies/ml, which is an acceptable value in comparison to the qPCR method. The specificity of the aptasensor was confirmed through cross-reactivity testing, while its selectivity was confirmed through plasma testing. The sample analysis showed 90% precision and 94% accuracy. It was concluded that the biosensor was adequately sensitive and specific for the detection of BVDV in plasma samples and could be used as a simple and rapid method on the farm.
Sujet(s)
Aptamères nucléotidiques , Techniques de biocapteur , Colorimétrie , Virus de la diarrhée virale bovine de type 1 , G-quadruplexes , Or , Nanoparticules métalliques , Or/composition chimique , Techniques de biocapteur/méthodes , Aptamères nucléotidiques/composition chimique , Colorimétrie/méthodes , Nanoparticules métalliques/composition chimique , Animaux , Bovins , Virus de la diarrhée virale bovine de type 1/génétique , Virus de la diarrhée virale bovine de type 1/isolement et purification , Génotype , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/virologie , Diarrhée virale bovine-maladie des muqueuses/sang , Simulation de docking moléculaireRÉSUMÉ
Bovine viral diarrhea virus (BVDV) is considered to be the most common agent of severe diarrhea in cattle worldwide, causing fever, diarrhea, ulcers, and abortion. Bovine herpesvirus 1 (BoHV-1) is also a major bovine respiratory disease agent that spreads worldwide and causes extensive damage to the livestock industry. Recombinase polymerase amplification (RPA) is a novel nucleic acid amplification method with the advantages of high efficiency, rapidity and sensitivity, which has been widely used in the diagnosis of infectious diseases. A dual RPA assay was developed for the simultaneous detection of BVDV and BoHV-1. The assay was completed at a constant temperature of 37 °C for 30 min. It was highly sensitive and had no cross-reactivity with other common bovine viruses. The detection rate of BVDV RPA in clinical samples (36.67%) was higher than that of PCR (33.33%), the detection rate of BoHV-1 RPA and PCR were equal. Therefore, the established dual RPA assay for BVDV and BoHV-1 could be a potential candidate for use as an immediate diagnostic.
Sujet(s)
Virus de la diarrhée virale bovine , Herpèsvirus bovin de type 1 , Techniques d'amplification d'acides nucléiques , Recombinases , Animaux , Bovins , Herpèsvirus bovin de type 1/génétique , Herpèsvirus bovin de type 1/isolement et purification , Techniques d'amplification d'acides nucléiques/méthodes , Recombinases/métabolisme , Virus de la diarrhée virale bovine/génétique , Virus de la diarrhée virale bovine/isolement et purification , Sensibilité et spécificité , Diarrhée virale bovine-maladie des muqueuses/virologie , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Infections à Herpesviridae/médecine vétérinaire , Infections à Herpesviridae/virologie , Infections à Herpesviridae/diagnostic , ADN viral/génétiqueRÉSUMÉ
Bovine Trypanosomiasis and other infectious diseases cause relevant loss for the livestock industry impacting productive/reproductive indices. This study intended to better understand the frequency, seasonality, and profile of infections associated with Bovine Trypanosomiasis. A total of 1443 serum samples were screened for T. vivax infection and other infectious diseases: Neosporosis, Leptospirosis, Bovine Leukosis Virus infection/(BLV), Infectious Bovine Rhinotracheitis/(IBR) or Bovine Viral Diarrhea/(BVD). Distinct methods were used for screening and diagnosis: immunofluorescence assay (Trypanosomiasis), ELISA (Neosporosis,BLV,IBR,BVD) and microscopic agglutination test (Leptospirosis). Our findings demonstrated that the seropositivity for Trypanosomiasis=57% was similar to Neosporosis=55%, higher than Leptospirosis=39% and BVL=34%, but lower than IBR=88% and BVD=71%. The seropositivity for Trypanosomiasis was higher in the autumn and lower in the winter. Regardless the season, the IBR seropositivity (min=73%;max=95%) was higher than Trypanosomiasis (min=48%;max=68%). Moreover, Neosporosis (min=71%;max=100%) and BVD (min=65%;max=76%) were more frequent than Trypanosomiasis in the summer, winter and spring. The diagnosis outcome revealed that Trypanosomiasis&IBR=43% and Trypanosomiasis&Neosporosis=35% were the most frequent co-infections with higher seropositivity in the autumn (58%) and summer (80%), respectively. Noteworthy, high seropositivity to Trypanosomiasis&BVD was registered in the autumn (46%). Together, our data re-enforce the relevance of differential diagnosis between Trypanosomiasis with other bovine infectious diseases and that differences in the seasonality profile is a relevant aspect to be considered while selecting the differential diagnosis to be applied.
Sujet(s)
Co-infection , Leptospirose , Saisons , Trypanosoma vivax , Animaux , Bovins , Co-infection/médecine vétérinaire , Co-infection/parasitologie , Co-infection/diagnostic , Femelle , Trypanosoma vivax/immunologie , Diagnostic différentiel , Leptospirose/médecine vétérinaire , Leptospirose/diagnostic , Leptospirose/épidémiologie , Coccidiose/médecine vétérinaire , Coccidiose/épidémiologie , Coccidiose/diagnostic , Trypanosomose bovine/épidémiologie , Trypanosomose bovine/diagnostic , Trypanosomose bovine/sang , Anticorps antiprotozoaires/sang , Rhinotrachéite infectieuse bovine/diagnostic , Rhinotrachéite infectieuse bovine/épidémiologie , Maladies des bovins/diagnostic , Maladies des bovins/parasitologie , Maladies des bovins/épidémiologie , Études séroépidémiologiques , Test ELISA/médecine vétérinaire , Neospora/immunologie , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologieRÉSUMÉ
Since being reported in 1979 and 2006, indirect fluorescent antibody (IFA) tests have not been reported to detect bovine viral diarrhea virus (BVDV) antibodies to our knowledge. Thus, we re-evaluated the efficacy and usefulness of IFA tests for BVDV serology. We tested 4 combinations of 2 antibody conjugates (fluorescein isothiocyanate [FITC]-conjugated rabbit IgG anti-bovine IgG; rabbit IgG F(ab')2 fragment anti-bovine IgG [F(ab')2 FITC-IgG]) and 2 washing solutions (PBS; carbonate-bicarbonate-buffered saline [CBBS]) to evaluate the specificity of an IFA test for BVDV. We compared the sensitivity of the optimal combination with virus neutralization (VN) tests and an ELISA, and compared IFA with VN titers against different genotype (subgenotype) strains. For the F(ab')2 FITC-IgG/CBBS combination, only 1 of the 156 (0.6%) 4-fold diluted cattle sera resulted in a nonspecific reaction; other combinations led to a much higher incidence (22.9-37.2%). For the F(ab')2 FITC-IgG/CBBS combination, IFA detection rates were identical (36 of 59) for BVDV1 and BVDV2 genotypes, and IFA titers against them were strongly correlated (r = 0.99). The antibody-detection rates of the IFA tests were almost identical to those of VN tests and the ELISA (κ: 0.96 and 0.89, respectively). The IFA titers against 4 strains (BVDV1a, BVDV1j, BVDV2a, and an unidentified strain) were similar, 1,024 to ≥4,096, although the VN titers were different. Thus, our IFA tests were specific and sensitive, and more useful than VN tests given that the IFA tests could evaluate the immune status of cattle using a representative strain, regardless of genotype (subgenotype).
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Maladies des bovins , Virus de la diarrhée virale bovine de type 1 , Virus de la diarrhée virale bovine , Bovins , Animaux , Lapins , Fluorescéine-5-isothiocyanate , Virus de la diarrhée virale bovine/génétique , Virus de la diarrhée virale bovine de type 1/génétique , Anticorps antiviraux , Immunoglobuline G , Diarrhée/médecine vétérinaire , Diarrhée virale bovine-maladie des muqueuses/diagnosticRÉSUMÉ
With the rapid development of cattle industry, bovine viral diarrhea virus (BVDV) is becoming widespread in China, which causes serious economic losses to the industry. Effective vaccination and viral surveillance are critical for the prevent and control of BVDV infection. In the present study, the immunogenic domain of E2 protein of BVDV-1 was expressed by prokaryotic pET-28a vector. Monoclonal antibodies (mAbs) against E2 protein were prepared and systemically examined by western blot, immunofluorescence assay, blocking ELISA (bELISA) and virus neutralization test (VNT). The mAb 1E2B3, which showed good reactivity and neutralizing activity to BVDV-1 strains, was selected for ELISA establishment. After a series of screening and optimization, a novel bELISA for highly sensitive and specific detection of BVDV-1 antibodies was established, using HRP-labeled 1E2B3 and recombinant E2 protein. ROC analysis of 91 positive and 84 negative reference bovine serum samples yielded the area under the curve (AUC) of 0.9903. A diagnostic specificity of 96.43 % and a sensitivity of 95.6 % were achieved when the cutoff value was set at 24.31 %. There was no cross reaction to the positive sera of classical swine fever virus (CSFV), BVDV-2, border disease virus (BDV), bovine parainfluenza virus type 3 (BPIV3), infectious bovine rhinotracheitis virus (IBRV), foot-and-mouth disease virus (FMDV), Mycoplasma bovis (M.bovis) and Brucella. The total agreement rate of bELISA with VNT was 93.96 % (249/265). In addition, the result of bELISA was positively correlated with neutralizing antibody titer, and the bELISA could well distinguish the serum samples before and after BVDV vaccination. These results indicate that the established bELISA in this study is specific, sensitive, simple and convenient, which provides technical support for the vaccine efficacy evaluation, prevention and control of BVD in the future.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Virus de la diarrhée virale bovine de type 1 , Virus de la diarrhée virale bovine , Animaux , Suidae , Bovins , Anticorps monoclonaux , Test ELISA/méthodes , Anticorps antiviraux , Protéines recombinantes , Diarrhée , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/prévention et contrôleRÉSUMÉ
BACKGROUND: Despite bovine viral diarrhoea virus and Chlamydia pecorum being important endemic diseases of cattle, there are limited reports of theirco-occurrence. CASE REPORT: Several 12-18-week-old, weaned Hereford calves presented with ill-thriftiness and neurological signs on a mixed cattle and sheep farm in South Australia in July 2021. Immune suppression resulting from transient infection with bovine viral diarrhoea virus (BVDV) is implicated in predisposing to infection with Chlamydia pecorum, the causative agent of sporadic bovine encephalopathy (SBE). Chlamydia spp. are difficult to culture in vitro or definitively identify based on current standard molecular based tests. In this case, diagnosis was confirmed by immunohistochemistry. CONCLUSION: To the authors' knowledge, this case report is the first to document BVDV transient infection occurring in conjunction with SBE. Given the current high prevalence of BVDV on Australian farms, such co-infections may have significant future clinical relevance. This case also highlights the need for appropriate tests, such as immunohistochemistry to demonstrate the causative organism in histological lesions and thus reduce the occurrence of false negative diagnosis.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Encéphalopathies , Chlamydia , Virus de la diarrhée virale bovine de type 1 , Virus de la diarrhée virale bovine , Maladies des ovins , Maladies virales , Animaux , Bovins , Ovis , Australie-Méridionale/épidémiologie , Australie/épidémiologie , Encéphalopathies/médecine vétérinaire , Diarrhée/médecine vétérinaire , Maladies virales/médecine vétérinaire , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Maladies des ovins/diagnostic , Maladies des ovins/épidémiologieRÉSUMÉ
The review provides an analysis of literature data on the persistent form of Bovine Viral diarrhea/Mucosal disease (BVD) and is focused on virus and host factors, including those related to immune response, that contribute the persistence of the virus. BVD is a cattle disease widespread throughout the world that causes significant economic damage to dairy and beef cattle. The disease is characterized by a variety of clinical signs, including damage to the digestive and respiratory organs, abortions, stillbirths and other failures of reproductive functions.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Maladies des bovins , Virus de la diarrhée virale bovine , Animaux , Grossesse , Femelle , Bovins , Virus de la diarrhée virale bovine/génétique , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée/médecine vétérinaireRÉSUMÉ
The lethality of the bovine viral diarrhea virus (BVDV) in cattle involves inapparent infection and various, typically subclinical, syndromes. Cattle of all ages are vulnerable to infection with the virus. It also causes considerable economic losses, primarily due to reduced reproductive performance. In the absence of treatment that can completely cure infected animals, detection of BVDV relies on highly sensitive and selective diagnosis methods. In this study, an electrochemical detection system was developed as a useful and sensitive system for the detection of BVDV to suggest the direction of diagnostic technology through the development of conductive nanoparticle synthesis. As a countermeasure, a more sensitive and rapid BVDV detection system was developed using the synthesis of electroconductive nanomaterials black phosphorus (BP) and gold nanoparticle (AuNP). To increase the conductivity effect, AuNP was synthesized on the BP surface, and the stability of BP was improved by using dopamine self-polymerization. Moreover, its characterizations, electrical conductivity, selectivity, and sensitivity toward BVDV also have been investigated. The BP@AuNP-peptide-based BVDV electrochemical sensor exhibited a low detection limit of 0.59 copies mL-1 with high selectivity and long-term stability (retaining 95% of its initial performance over 30 days).
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Virus de la diarrhée virale bovine , Nanoparticules métalliques , Animaux , Bovins , Or , Diarrhée virale bovine-maladie des muqueuses/diagnostic , PeptidesRÉSUMÉ
BACKGROUND: Bovine viral diarrhoea virus (BVDV) causes substantial economic losses to the cattle industry; however, control and eradication can be achieved by identifying and removing persistently infected cattle from the herd. Each UK nation has separate control programmes. The English scheme, BVDFree, started in 2016 and is voluntary. METHODS: We analysed the test results submitted to BVDFree from 5847 herds between 2016 and 2020. RESULTS: In 2020, 13.5% of beef breeders and 20.0% of dairy herds that submitted tests had at least one positive (virus/antibody) test result. Although lower than in previous years, there was no clear trend in the proportion of positive tests over time. In virus testing herds, 0.4% of individual tests were positive in 2020, and 1.5% of individual tests were positive in BVDV-positive virus testing herds. Dairy herds and larger herds were more likely to join BVDFree, and dairy herds were also more likely to virus test than beef breeder herds. Larger herds, herds that used virus testing and herds that had BVDV-positive test results were more likely to continue submitting tests to BVDFree. CONCLUSIONS: The findings provide a benchmark for the status of BVDV control in England; continued analysis of test results will be important to assess progress towards eradication.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Maladies des bovins , Virus de la diarrhée virale bovine , Animaux , Anticorps antiviraux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Diarrhée virale bovine-maladie des muqueuses/prévention et contrôle , Bovins , Diarrhée/médecine vétérinaire , Angleterre/épidémiologieRÉSUMÉ
Bovine viral diarrhoea virus (BVDV) infection is a worldwide distributed animal disease. BVDV is the causal agent of congenital defects, diarrhea, reproductive failure, and contaminating biological products. Virus Neutralization test (VNT) as a gold standard method is used for detection of BVDV. Although this assay is very sensitive and specific, it has disadvantages including requires to an experienced person and cell culture facilities. VNT is time-consuming. It is important to design a method that does not have the mentioned disadvantages. So, in-house indirect enzyme linked immunosorbent assay (i-ELISA) was developed for laboratories where it is not possible to perform VNT. The system was made using NADL strain of BVDV and MDBK cell line. This ELISA system was compared with a commercial ELISA kit using 99 bovine sera. Coefficient of variation (CV) was calculated 3.9% and 4.8% for the positive and negative control, respectively for the designed i-ELISA system. The sensitivity, specificity, and accuracy of i-ELISA system was 88%, 53.6%, and 70.7% respectively. Based on our result correlation between in- house and commercial ELISA kit for detection of antibody against BVDV in bovine sera was significant (Kappa coefficient =0.41, p < 0.05). Results of the present study suggested that an in-house ELISA as an affordable and confident system for primary screening of the sera used for biological product.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Virus de la diarrhée virale bovine de type 1 , Virus de la diarrhée virale bovine , Animaux , Anticorps antiviraux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Bovins , Diarrhée , Test ELISA/méthodes , Test ELISA/médecine vétérinaire , Humains , Tests de neutralisationRÉSUMÉ
BACKGROUND: Control programs were implemented in several countries against bovine viral diarrhea (BVD), one of the most significant cattle diseases worldwide. Most of the programs rely on serological diagnostics in any phase of the program. For the detection of antibodies against BVD virus (BVDV), neutralization tests as well as a variety of (commercially available) ELISAs are used. Here, test systems applied in various laboratories were evaluated in the context of an international interlaboratory proficiency trial. A panel of standardized samples comprising five sera and five milk samples was sent to veterinary diagnostic laboratories (n=51) and test kit manufacturers (n=3). RESULTS: The ring trial sample panel was investigated by nine commercially available antibody ELISAs as well as by neutralization tests against diverse BVDV-1, BVDV-2 and/or border disease virus (BDV) strains. The negative serum and milk sample as well as a serum collected after BVDV-2 infection were mostly correctly tested regardless of the applied test system. A serum sample obtained from an animal immunized with an inactivated BVDV-1 vaccine tested positive by neutralization tests or by total antibody or Erns-based ELISAs, while all applied NS3-based ELISAs gave negative results. A further serum, containing antibodies against the ovine BDV, reacted positive in all applied BVDV ELISAs, a differentiation between anti-BDV and anti-BVDV antibodies was only enabled by parallel application of neutralization tests against BVDV and BDV isolates. For the BVDV antibody-positive milk samples (n=4), which mimicked prevalences of 20% (n=2) or 50% (n=2), considerable differences in the number of positive results were observed, which mainly depended on the ELISA kit and the sample incubation protocols used. These 4 milk samples tested negative in 43.6%, 50.9%, 3.6% and 56.4%, respectively, of all investigations. Overall, negative results occurred more often, when a short sample incubation protocol instead of an over-night protocol was applied. CONCLUSIONS: While the seronegative samples were correctly evaluated in most cases, there were considerable differences in the number of correct evaluations for the seropositive samples, most notably when pooled milk samples were tested. Hence, thorough validation and careful selection of ELISA tests are necessary, especially when applied during surveillance programs in BVD-free regions.
Sujet(s)
Virus de la maladie de Border , Diarrhée virale bovine-maladie des muqueuses , Virus de la diarrhée virale bovine de type 1 , Virus de la diarrhée virale bovine , Maladies des ovins , Animaux , Anticorps antiviraux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Diarrhée virale bovine-maladie des muqueuses/prévention et contrôle , Bovins , Diarrhée/médecine vétérinaire , Test ELISA/méthodes , Test ELISA/médecine vétérinaire , Lait/composition chimique , Ovis , Vaccins inactivésRÉSUMÉ
BACKGROUND: Between 2007 and 2011 several thousands of calves died from bovine neonatal pancytopenia (BNP), a bleeding syndrome triggered by vaccine induced alloantibodies from the dams. Following withdrawal of the involved bovine viral diarrhoea virus (BVDv) vaccine, the incidence of this condition rapidly decreased, with no reported cases in the last 5 years. Here, we report a recent immune-mediated pancytopenia in three calves from two different suckler herds, clinically indistinguishable from BNP. CASE PRESENTATION: Three Belgian Blue suckler calves from two different farms, aged around two weeks, showed multiple bleedings disseminated on the skin and petechiae and ecchymoses on the mucosae. Blood examination confirmed anaemia, leukopenia and thrombocytopenia. BVDv infection was excluded. Despite blood transfusion and cortisone therapy, all three animals died. Necropsy and histology confirmed bone marrow depletion. Binding of IgG from the dams on leukocytes of the calves was demonstrated by flow cytometry. Two calves, originating from the same farm, received colostrum from the same dam. None of the calves were given colostrum replacers or colostrum supplements. No link with the BNP causing BVDv vaccine could be evidenced. However, dams had been vaccinated against bovine herpesvirus 1, parainfluenza-3 virus, bovine respiratory syncytial virus and bluetongue virus serotype 8. CONCLUSIONS: Alloimmune mediated pancytopenia was evidenced in three animals, clinically and pathologically indistinguishable from BNP. Whether this disease is again vaccine mediated remains to be determined.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Maladies des bovins , Virus de la diarrhée virale bovine , Pancytopénie , Vaccins antiviraux , Animaux , Animaux nouveau-nés , Anticorps antiviraux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Bovins , Maladies des bovins/diagnostic , Virus de la diarrhée virale bovine/immunologie , Pancytopénie/médecine vétérinaire , Vaccins antiviraux/effets indésirablesRÉSUMÉ
Bovine viral diarrhea virus (BVDV) infection results in a wide variety of clinical manifestations and is a pathogen that is able to cause huge economic losses in the cattle industry worldwide. It is important to identify cattle that are persistently infected (PI) by BVDV within the herd as early as possible because PI animals are the main reservoir of the virus. In contrast, cattle who are acutely infected (AI) with BVDV show various clinical signs, but most cattle show either mild symptoms or are asymptomatic. In general, AI and PI animals can be distinguished by repeat testing within an interval of at least 21 days. However, we found a rare case of a BVDV2-infected AI animal with long-term viral presence, making it indistinguishable from PI through two tests within an interval of 21 days. As a result, we diagnosed one infected animal as AI after 35 days from the initial sample collection via multiple analyses. Our findings recommend performing an additional test using samples that have been collected after 14-21 days from the second sample collection in cases where it is difficult to accurately differentiate an AI diagnosis from a PI diagnosis after only two tests. Additionally, our analysis exhibits that monitoring the number of copies of viruses with similar genomes in the sera by means of quantitative real-time RT-PCR through several sample collections periods might be useful to distinguish AI from PI. Furthermore, our data suggest that the AI animals with a long-term viral presence who show test results similar to those of PI animals might be the result of a coincidental combination of various factors that are present in cattle fields. These findings provide useful information that can be used to improve the diagnosis of BVDV in the field.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses/diagnostic , Virus de la diarrhée virale bovine de type 2 , Régions 5' non traduites , Maladie aigüe , Animaux , Anticorps neutralisants/sang , Anticorps antiviraux/sang , Diarrhée virale bovine-maladie des muqueuses/virologie , Bovins , Virus de la diarrhée virale bovine de type 2/classification , Virus de la diarrhée virale bovine de type 2/génétique , Virus de la diarrhée virale bovine de type 2/immunologie , Virus de la diarrhée virale bovine de type 2/isolement et purification , Phylogenèse , Réaction de polymérisation en chaine en temps réel , RT-PCR , Manipulation d'échantillons , Facteurs tempsRÉSUMÉ
Pooled samples are used in veterinary and human medicine as a cost-effective approach to monitor disease prevalence. Nonetheless, there is limited information on the effect of pooling on test performance, and research is required to determine the appropriate number of samples which can be pooled. Therefore, this study aimed to evaluate the use of pooled serum samples as a herd-level surveillance tool for infectious production-limiting diseases: bovine viral diarrhoea (BVD), infectious bovine rhinotracheitis (IBR), enzootic bovine leukosis (EBL) and Neospora caninum (NC), by investigating the maximum number of samples one can pool to identify one positive animal, using commercial antibody-detection ELISAs. Four positive field standards (PFS), one for each disease, were prepared by pooling highly positive herd-level samples diagnosed using commercially available ELISA tests. These PFS were used to simulate 18 pooled samples ranging from undiluted PFS to a dilution representing 1 positive in 1,000 animals using phosphate-buffered saline as diluent. A 1:10 dilution of the PFS resulted in positive results for IBR, BVD and EBL. Moreover, for IBR and BVD, results were still positive at 1:100 and 1:30 dilutions, respectively. However, for NC, a lower dilution (8:10) was required for a seropositive result. This study indicates that, at herd-level, the use of pooled serum is a useful strategy for monitoring infectious diseases (BVD, IBR and EBL) but not NC, using readily available diagnostic assays.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Maladies des bovins , Virus de la diarrhée virale bovine , Leucose bovine enzootique , Rhinotrachéite infectieuse bovine , Animaux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Bovins , Maladies des bovins/diagnostic , Maladies des bovins/épidémiologie , Test ELISA/médecine vétérinaire , Rhinotrachéite infectieuse bovine/diagnostic , Rhinotrachéite infectieuse bovine/épidémiologieRÉSUMÉ
Bovine viral diarrhea virus (BVDV) is a viral pathogen associated with serious problems in the cattle industry. Cattle persistently infected (PI) with BVDV are mild or asymptomatic; however, they become a source of BVDV transmission to other cattle. Hence, it is important to rapidly identify and remove the PI animals from cattle herds. Whereas cattle acutely infected (AI) with BVDV have various symptoms, yet they generally recover within 3 weeks. However, there is a paucity of information concerning clinical characteristics of AI cattle. Further accumulation of information would be required to accurately diagnose AI cattle with BVDV. Here, we attempted to obtain valuable information via various analyses using a case report of BVD outbreak that occurred for approximately four months in Iwate Prefecture in 2017. Using eight calves and multiple tests (real-time RT-PCR, virus isolation, enzyme-linked immunosorbent assay, and virus neutralization assay) over 6 weeks, we diagnosed the continuous BVD outbreak as an acute infection and not a persistent one. Additionally, we revealed that the sporadic case was caused by low pathogenic BVDV2 via BVDV genotyping and phylogenetic analysis. The data suggest that BVDV2 AI animals might also be a source of transmission to susceptible calves; hence, it might persist for a long period owing to multiple AI animals. These findings provide useful information to diagnose AI and PI cattle with BVDV in the field.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses/transmission , Virus de la diarrhée virale bovine de type 2/génétique , Virus de la diarrhée virale bovine de type 2/pathogénicité , Diarrhée/médecine vétérinaire , Diarrhée/virologie , Épidémies de maladies/médecine vétérinaire , Maladie aigüe , Facteurs âges , Animaux , Anticorps antiviraux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Bovins , Industrie laitière , Virus de la diarrhée virale bovine de type 2/classification , Virus de la diarrhée virale bovine de type 2/isolement et purification , Prédisposition aux maladies , Japon/épidémiologie , Facteurs tempsRÉSUMÉ
AIMS: To explore recommendations that New Zealand veterinarians make for diagnosing and managing bovine viral diarrhoea (BVD) in cattle herds under different clinical scenarios and their opinions towards potential barriers and opportunities for implementing BVD control programmes in New Zealand. METHODS: A cross-sectional survey of registered veterinarians in New Zealand was conducted in 2019. Respondents were asked about the approaches they would use to manage BVD under different clinical scenarios as well as their opinions on national BVD control. A subset of veterinarians completed a more in-depth survey providing additional free-text responses on a range of different BVD topics. Descriptive statistics were provided for all quantitative study variables and the free-text responses were also analysed to generate further insights into veterinarians' perceptions towards BVD management. RESULTS: The cross-sectional survey was completed by 101 of an estimated 870 (11.6%) cattle veterinarians. Thirty-five veterinarians completed the in-depth survey. There was wide variation in the BVD diagnostic testing and vaccination protocols that respondents recommended under different clinical scenarios. Annual bulk milk BVD testing was perceived as a valuable tool for initiating BVD discussions with dairy farmers. Respondents indicated that beef farmers were more difficult to engage in BVD control largely due to the logistical challenges of yarding cattle at the appropriate times to implement interventions, with many farmers only contacting veterinarians after experiencing a BVD outbreak Most respondents (91/101; 90%) believed it was possible to eradicate BVD from New Zealand, but cited lack of farmer awareness and poor compliance with management recommendations as significant barriers. The measure with the most support for inclusion in a compulsory national eradication programme was requiring farmers to declare the status of their animals prior to sale while the least supported measure was requiring farmers to double fence boundaries to prevent nose-to-nose contact with neighbouring stock. Although respondents highlighted the need for farmers and industry to support any national eradication programme in order for it to be successful, there was also recognition that veterinarians could be more pro-active in engaging with farmers particularly in discussions around the economics of BVD. CONCLUSIONS AND CLINICAL RELEVANCE: While the survey respondents appeared to be highly supportive of BVD control, it was perceived that financial and logistical barriers existed that could impede farmer engagement. Further extension efforts may be needed to ensure that veterinarians are presenting clear and consistent recommendations about BVD management to farmers.Abbreviations: BVD: Bovine viral diarrhoea; NAIT: National Animal Identification and Tracing System; PI: Persistently infected.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Maladies des bovins , Virus de la diarrhée virale bovine , Vétérinaires , Élevage , Animaux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Diarrhée virale bovine-maladie des muqueuses/prévention et contrôle , Bovins , Études transversales , Diarrhée/médecine vétérinaire , Humains , Nouvelle-Zélande/épidémiologieRÉSUMÉ
Bovine viral diarrhea virus (BVDV) causes significant economic loss in cattle. Detection of persistently infected (PI) animals is an important control measure, but persistence of maternal antibodies may result in false-negative test results. We assessed the sensitivity and specificity of 2 antigen ELISAs (Idexx BVDV Ag/Serum Plus and BVDV PI X2) and a reverse-transcription real-time PCR (RT-rtPCR; Idexx RealPCR BVDV) assay for detecting PI calves. Ear notch samples were collected from 1,030 calves ~3, 10, 24, and 38 d old (days 3, 10, 24, and 38). All day 38 samples were tested using 2 antigen ELISAs and RT-rtPCR, and any calf that tested positive by any of these tests was blood sampled at ~100 d old (day 100) for antigen and antibody testing by ELISA; samples collected on days 3, 10, and 24 were tested using the antigen ELISAs and PCR. Calves were defined as PI if they were test-positive on day 38 by either ELISA or PCR and were antigen-positive on day 100. Twenty-six calves were PCR BVDV test-positive and one was BVDV PI X2 ELISA-positive at day 38. Five calves were defined as PI, and all tested positive by ELISAs and RT-PCR assay on days 3, 10, and 24. The sensitivity and specificity were 100% for both antigen ELISAs and 96.7% and 100%, respectively, by RT-rtPCR. Test results were not affected by calf age, suggesting that testing for PI calves can be undertaken at any age.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses/diagnostic , Virus de la diarrhée virale bovine/isolement et purification , Test ELISA/médecine vétérinaire , Réaction de polymérisation en chaîne/médecine vétérinaire , Facteurs âges , Animaux , Antigènes viraux , Bovins , Femelle , Sensibilité et spécificitéRÉSUMÉ
In 2019, diarrhea cases occurred on cattle farms in Qionglai and Guang'an, Sichuan Province. Two out of 20 (10%) serum and nasal swab samples were positive when tested using a bovine viral diarrhea virus (BVDV) antigen-capture ELISA kit. Two non-cytopathic strains of BVDV were isolated and named QL1903 and GA190608, respectively. The nucleotide sequences of the genomes of the two isolates were 89.52% identical. Phylogenetic analysis based on the 5'-UTR sequence revealed that the BVDV isolate QL1903 belonged to BVDV subtype 1b, whereas isolate GA190608 clustered with strains HN1814, EN-19, and BJ09_26 in a separate branch, which has tentatively been classified as a new genetic subtype, "1v".
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses/virologie , Virus de la diarrhée virale bovine de type 1/classification , Virus de la diarrhée virale bovine de type 1/génétique , Régions 5' non traduites/génétique , Animaux , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Bovins , Lignée cellulaire , Virus de la diarrhée virale bovine de type 1/immunologie , Virus de la diarrhée virale bovine de type 1/isolement et purification , Variation génétique , Génome viral/génétique , Génotype , Phylogenèse , ARN viral/génétique , Protéines virales/immunologieRÉSUMÉ
Bovine viral diarrhea (BVD) is a major worldwide disease with negative economic impact on cattle production. Successful control programs of BVD require the identification and culling of persistently infected (PI) animals with bovine viral diarrhea virus (BVDV). A variety of diagnostic tests are available to detect BVDV, but no comparison has been performed among those tests in Argentina. Sera collected from 2864 cattle, belonging to 55 herds from three Argentinean provinces, were analyzed by nested RT-PCR (RT-nPCR) to detect BVDV for diagnostic purposes. Additionally, this study evaluated the agreement of the RT-nPCR along with virus isolation, antigen-capture ELISA, and real-time RT-PCR for BVDV detection in archived bovine serum samples (n = 90). The RT-nPCR was useful for BVDV detection in pooled and individual serum samples. BVDV was detected in 1% (29/2864) of the cattle and in 20% (11/55) of the herds. The proportion of BVDV-positive sera was not statistically different among the tests. In addition, comparisons showed high agreement levels, with the highest values between both RT-PCR protocols. The frequency of BVDV infection at individual and herd level was lower than the reported values worldwide. Since follow-up testing was not performed, the frequency of PI cattle was unknown. Also, this study demonstrated that the four diagnostic tests can be used reliably for BVDV identification in individual serum samples. Further epidemiologically designed studies that address prevalence, risk factors, and economic impact of BVDV in Argentina will be necessary to implement effective control programs.
Sujet(s)
Diarrhée virale bovine-maladie des muqueuses/sang , Diarrhée virale bovine-maladie des muqueuses/diagnostic , Virus de la diarrhée virale bovine/immunologie , Techniques de diagnostic moléculaire/normes , Techniques de diagnostic moléculaire/médecine vétérinaire , Tests sérologiques/normes , Tests sérologiques/médecine vétérinaire , Animaux , Argentine , Bovins , Virus de la diarrhée virale bovine/génétique , Virus de la diarrhée virale bovine/isolement et purification , Limite de détection , Techniques de diagnostic moléculaire/méthodes , Tests sérologiques/méthodes , SérumRÉSUMÉ
Infection of bulls with bovine viral diarrhoea virus (BVDV) can result in the development of virus persistence, confined to the reproductive tract. These bulls develop a normal immune response with high neutralizing antibody titres. However, BVDV can be excreted in the semen for a prolonged period. Although relatively rare, in this study we describe six separate cases in bulls being prepared for admission to artificial breeding centres. Semen samples were tested in a pan-Pestivirus-reactive real-time PCR assay and viral RNA was detected in semen from five of the bulls for three to eight months after infection. In one bull, virus was detected at low levels for more than five years. This bull was found to have one small testis. When slaughtered, virus was only detected in the abnormal testis. The low levels of BVDV in the semen of these bulls were only intermittently detected by virus isolation in cell culture. This virus-contaminated semen presents a biosecurity risk and confirms the need to screen all batches of semen from bulls that have been previously infected with BVDV. The use of real-time PCR is recommended as the preferred laboratory assay for this purpose.